Ciprofloxacin-induced cutaneous adverse drug events: a systematic review of descriptive studies.

Ananth KashyapSahana SreenivasanAsha K Rajan Muhammed Rashid Manik Chhabra

Published in: Journal of basic and clinical physiology and pharmacology (2021)

Management of the CIPRO-induced CADRs is recommended with the complete cessation of the CIPRO, followed by supportive management with oral or topical glucocorticoids, emollients, and topical moisturizers. CIPRO is likely to cause CADRs, physicians should be vigilant while prescribing it to the patients.

Keyphrases

adverse drug
primary care
high glucose
end stage renal disease
diabetic rats
drug induced
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
emergency department
pseudomonas aeruginosa
peritoneal dialysis
oxidative stress
patient reported